Bank of New York Mellon Corp
BankPosition in NTLA — Intellia Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in NTLA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,204,957
+$1,380,284 QoQ
Shares Held
328,000
+4.4% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. NTLA ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in NTLA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,204,957 | 328,000 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,824,673 | 314,202 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $5,406,371 | 313,050 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,918,754 | 311,168 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,004,612 | 281,943 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $3,318,597 | 284,614 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $5,925,466 | 288,344 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,153,164 | 364,306 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $9,958,754 | 362,005 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $12,000,708 | 393,595 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $12,637,025 | 399,653 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $16,273,093 | 399,046 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $13,713,046 | 367,938 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $13,214,584 | 378,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,135,350 | 341,947 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,514,488 | 299,739 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $21,406,473 | 294,571 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $34,965,812 | 295,719 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $40,103,468 | 298,945 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $42,600,946 | 263,115 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $16,285,984 | 202,928 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $3,736,822 | 187,969 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,922,520 | 186,609 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,115,372 | 172,966 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||